產(chǎn)品名稱(chēng) | BH3結(jié)構(gòu)域凋亡誘導(dǎo)蛋白抗體 |
英文名稱(chēng) | Anti-Bid |
規(guī)格 | 0.1ml/100μg 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱(chēng) Anti-Bid
中文名稱(chēng) BH3結(jié)構(gòu)域凋亡誘導(dǎo)蛋白抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 腫瘤 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 新陳代謝
蛋白分子量 predicted molecular weight: 21kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanBid C-terminus
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -197 °C for oneyear.
別 名 Apoptic death agonist; Apoptotic death agonist;Apoptotic death agonist BID; BH3 interacting domain death agonist; BH3interacting domain death agonist; BH3 interacting domain death agonist p11; BH3interacting domain death agonist p13; BH3 interacting domain death agonist p15;BH3-interacting domain death agonist p11; BID; BID isoform ES(1b); BID isoformL(2); BID isoform Si6; BID_HUMAN; Desmocollin type 4; FP497; HGNC:1050; HumanBID coding sequence; MGC15319; MGC42355; p11 BID; p13 BID; p15 BID; p22 BID.
